| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2017-05-05 | laquinimod | relapsing-remitting multiple sclerosis (RRMS) | 3 | Teva Pharmaceuticals (Israel) Active Biotech (Sweden) | Autoimmune diseases - Neurodegenerative diseases |
| 2017-05-05 | metreleptin (analog of the human hormone leptin) | generalized lipodystrophy | Novelion Therapeutics | Hepatic diseases - Liver diseases | |
| 2017-05-04 | HB-101 | cytomegalovirus infections | 1 | Hookipa Biotech (Austria) | Infectious diseases |
| 2017-05-04 | emricasan | NASH (non-alcoholic steatohepatitis) | 2b | Conatus Pharmaceuticals (USA - CA) | Hepatic diseases - Liver diseases |
| 2017-05-04 | OMP-313M32 (anti-TIGIT) | solid tumors | 1 | OncoMed Pharmaceuticals (USA - CA) | Cancer - Oncology |
| 2017-05-04 | StrataGraft® regenerative skin tissue | healing of excised full-thickness complex skin defects resulting from acute traumatic skin loss | 2 | Mallinckrodt (UK) | Dermatological diseases |
| 2017-05-04 | ADC-1013/JNJ-64457107 | preclinical | Alligator Bioscience (Sweden) | ||
| 2017-05-04 | ARGX-113 | myasthenia gravis | 2 | Argen-X (Belgium - The Netherlands) | Rare diseases - Genetic diseases - Neuromuscular diseases |
| 2017-05-03 | resminostat (oral pan-histone deacetylase (HDAC) inhibitor) | mycosis fungoides, Sezary syndrome, advanced-stage cutaneous T-cell lymphoma (CTCL). | 2 | 4SC (Germany) | Cancer - Oncology |
| 2017-05-03 | pain | Grunenthal (Germany) 23andMe (USA - CA) | CNS diseases - Neurological diseases | ||
| 2017-05-03 | Sarconeos (formerly SARCOB BIO101) | sarcopenic obesity | 2a | Biophytis (France) | Muscle disorders |
| 2017-05-03 | RGT100 | solid tumors, lymphoma | 1-2 | Rigontec (Germany) | Cancer - Oncology |
| 2017-05-02 | Feraheme® (ferumoxytol) | iron deficiency anemia (IDA) | 3 | Amag Pharmaceuticals (USA - MA) | Metabolic diseases |
| 2017-05-02 | EB-101 (gene corrected skin grafts) | epidermolysis bullosa | 1-2 | Abeona Therapeutics (USA - NY) | Rare diseases - Genetic diseases - Dermatological diseases |
| 2017-05-02 | Baxdela® (delafloxacin) | acute bacterial skin and skin structure infections (ABSSSI) | 3 | Melinta Therapeutics (USA - CT) | Infectious diseases |
| 2017-05-02 | oral leptin capsule | obesity | Oramed Pharmaceuticals (Israel) | Metabolic diseases | |
| 2017-05-02 | SENS-401 | prevention of cisplatin-induced ototoxicity | preclinical | Sensorion (France) | Otorhinolaryngology |
| 2017-05-02 | GMI-1271, GMI-1359 | breast cancer | preclinical | GlycoMimetics (USA - Md) | Cancer - Oncology |
| 2017-05-01 | TSR-033 | 1 | Tesaro (US - MA) | Cancer - Oncology | |
| 2017-05-01 | IMGN853 - mirvetuximab soravtansine | FRalpha-positive platinum-resistant ovarian cancer | 1-2 | Immunogen (USA - MA) | Cancer - Oncology |
